Clinical Trials Browser

Cardiotoxicity × empagliflozin × Clear all

NCT06844669 2026-05-13

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Phase 2 Terminated

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT05271162 2025-11-21

EMPACT

Phase 3 Recruiting

Cardiotoxicity